| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/31/2026 | ±2.4% | +0.2% | over-priced |
| 05/01/2026 | ±1.9% | -0.4% | over-priced |
| 02/25/2026 | ±2.6% | +3.2% | under-priced |
| 10/31/2025 | ±1.6% | +0.0% | over-priced |
| 08/01/2025 | ±1.5% | -1.6% | under-priced |
| 05/02/2025 | ±2.1% | +1.5% | over-priced |
| 02/27/2025 | ±2.3% | +0.6% | over-priced |
| 11/01/2024 | ±1.7% | -0.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $2.45 | $0 | $1.8B |
| Q1 FY2026 | $2.24 | $0 | $1.6B |
| Q4 FY2025 | — | $0 | $1.5B |
| Q3 FY2025 | $1.88 | $0 | $1.4B |
Bank of New York Mellon Corporation (BNY) reports in 10 days, with the next report estimated for 10/30/2026. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced BNY's earnings risk. Fundamentals into the print: EPS up 26.9% year-over-year, revenue up 0.0%. QuantLogix's live 5-factor engine currently reads BNY as a buy at 63/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →